Clinical trialNCT00422981CompletedPhase 2Interventional

Safety, Tolerability and Efficacy Study to Evaluate Subjects With Mild Cognitive Impairment

SponsorAllon TherapeuticsEnrollment144Mild Cognitive Impairment, So Stated

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to find out if different doses of Investigational Drug are safe, tolerable, and if they have an effect on Mild Cognitive Impairment (MCI).

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Donald E Schmechel, MD
Memory Assessment and Research Services
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Pivotal Research
Peoria, Arizona, United States
Collaborative Neuroscience Network
Garden Grove, California, United States
Synergy Research
National City, California, United States
Pacific Research Network, Inc
San Diego, California, United States
Meridien Research
Brooksville, Florida, United States
Clinical Neuroscience Solutions, Inc.
Jacksonville, Florida, United States
Clinical Neuroscience Solutions
Orlando, Florida, United States
Meridien Research
Tampa, Florida, United States
Stedman Clinical Trials
Tampa, Florida, United States
Clinical Research Center of Indian River Medical Center
Vero Beach, Florida, United States
Comprehensive Neuroscience
Hoffman Estates, Illinois, United States
the Memory Enhancement Center of America
Long Branch, New Jersey, United States
Spri Clinical Trials
Brooklyn, New York, United States
Memory Assessment and Research Services
Wilmington, North Carolina, United States
Neurology & Neuroscience Center of Ohio
Toledo, Ohio, United States
Clinical Neuroscience Solutions, Inc
Memphis, Tennessee, United States
Senior Adults Speciality Research
Austin, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

AL-108Placebo

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Jan 2007
Primary completion: 31 Jan 2008
Completion: 31 Jan 2008
Last update posted: 24 Oct 2012
Registered enrollment: 144
Registry id: NCT00422981

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.